EMEA-002493-PIP01-18-M06 - paediatric investigation plan
Nedosiran
PIPHuman
Key facts
- Active Substance
- Nedosiran
- Therapeutic area
- Congenital, familial and genetic disorders
- Uro-nephrology
- Decision number
- P/0064/2024
- PIP number
- EMEA-002493-PIP01-18-M06
- Pharmaceutical form(s)
- Solution for injection
- Condition(s) / indication(s)
- Treatment of primary hyperoxaluria
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
Novo Nordisk A/S
E-mail: paediatrics@novonordisk.com
Tel.: +45 44444848- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date